Recurrent Respiratory Papillomatosis (RRP) is a rare and chronic viral disease that affects the respiratory tract. It is caused by the human papillomavirus (HPV), specifically types 6 and 11. RRP primarily affects children and young adults, although it can occur at any age.
The condition is characterized by the growth of benign tumors, known as papillomas, in the airway passages, including the larynx, trachea, and lungs. These papillomas can cause a range of symptoms, such as hoarseness, difficulty breathing, coughing, and recurrent respiratory infections.
RRP is a chronic condition that requires long-term management, as the papillomas tend to regrow even after surgical removal. Treatment options include surgical removal of the papillomas, laser therapy, and antiviral medications. Regular monitoring and follow-up are essential to manage the disease and prevent complications.
While RRP is a challenging condition to manage, advancements in medical treatments and ongoing research offer hope for improved outcomes and quality of life for individuals affected by this condition.